MAPT and Alzheimer disease: These results are in line with previous studies, showing an increase in Aβ and p-tau protein expression, as well as immune/inflammatory cell activation in intestinal tissues from TgCRND8 and APP/PS1 mice (genetic models of AD) since the early stages of AD [11,37].